Activation of TAF9 via Danshensu-Induced Upregulation of HDAC1 Expression Alleviates Non-alcoholic Fatty Liver Disease
Fatty acid β-oxidation is an essential pathogenic mechanism in nonalcoholic fatty liver disease (NAFLD), and TATA-box binding protein associated factor 9 (TAF9) has been reported to be involved in the regulation of fatty acid β-oxidation. However, the function of TAF9 in NAFLD, as well as the mechan...
Guardado en:
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/5e91aa1943114e12a54876c54199f945 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:5e91aa1943114e12a54876c54199f945 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:5e91aa1943114e12a54876c54199f9452021-12-02T11:43:02ZActivation of TAF9 via Danshensu-Induced Upregulation of HDAC1 Expression Alleviates Non-alcoholic Fatty Liver Disease1663-981210.3389/fphar.2021.775528https://doaj.org/article/5e91aa1943114e12a54876c54199f9452021-12-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fphar.2021.775528/fullhttps://doaj.org/toc/1663-9812Fatty acid β-oxidation is an essential pathogenic mechanism in nonalcoholic fatty liver disease (NAFLD), and TATA-box binding protein associated factor 9 (TAF9) has been reported to be involved in the regulation of fatty acid β-oxidation. However, the function of TAF9 in NAFLD, as well as the mechanism by which TAF9 is regulated, remains unclear. In this study, we aimed to investigate the signaling mechanism underlying the involvement of TAF9 in NAFLD and the protective effect of the natural phenolic compound Danshensu (DSS) against NAFLD via the HDAC1/TAF9 pathway. An in vivo model of high-fat diet (HFD)-induced NAFLD and a palmitic acid (PA)-treated AML-12 cell model were developed. Pharmacological treatment with DSS significantly increased fatty acid β-oxidation and reduced lipid droplet (LD) accumulation in NAFLD. TAF9 overexpression had the same effects on these processes both in vivo and in vitro. Interestingly, the protective effect of DSS was markedly blocked by TAF9 knockdown. Mechanistically, TAF9 was shown to be deacetylated by HDAC1, which regulates the capacity of TAF9 to mediate fatty acid β-oxidation and LD accumulation during NAFLD. In conclusion, TAF9 is a key regulator in the treatment of NAFLD that acts by increasing fatty acid β-oxidation and reducing LD accumulation, and DSS confers protection against NAFLD through the HDAC1/TAF9 pathway.Ruiwen WangZhecheng WangRuimin SunRong FuYu SunMeiyang ZhuYunfei GengDongyan GaoXiaofeng TianYan ZhaoJihong YaoFrontiers Media S.A.articleNAFLDTAF9HDAC1DanshensuFATTY ACID β-OXIDATIONLD accumulationTherapeutics. PharmacologyRM1-950ENFrontiers in Pharmacology, Vol 12 (2021) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
NAFLD TAF9 HDAC1 Danshensu FATTY ACID β-OXIDATION LD accumulation Therapeutics. Pharmacology RM1-950 |
| spellingShingle |
NAFLD TAF9 HDAC1 Danshensu FATTY ACID β-OXIDATION LD accumulation Therapeutics. Pharmacology RM1-950 Ruiwen Wang Zhecheng Wang Ruimin Sun Rong Fu Yu Sun Meiyang Zhu Yunfei Geng Dongyan Gao Xiaofeng Tian Yan Zhao Jihong Yao Activation of TAF9 via Danshensu-Induced Upregulation of HDAC1 Expression Alleviates Non-alcoholic Fatty Liver Disease |
| description |
Fatty acid β-oxidation is an essential pathogenic mechanism in nonalcoholic fatty liver disease (NAFLD), and TATA-box binding protein associated factor 9 (TAF9) has been reported to be involved in the regulation of fatty acid β-oxidation. However, the function of TAF9 in NAFLD, as well as the mechanism by which TAF9 is regulated, remains unclear. In this study, we aimed to investigate the signaling mechanism underlying the involvement of TAF9 in NAFLD and the protective effect of the natural phenolic compound Danshensu (DSS) against NAFLD via the HDAC1/TAF9 pathway. An in vivo model of high-fat diet (HFD)-induced NAFLD and a palmitic acid (PA)-treated AML-12 cell model were developed. Pharmacological treatment with DSS significantly increased fatty acid β-oxidation and reduced lipid droplet (LD) accumulation in NAFLD. TAF9 overexpression had the same effects on these processes both in vivo and in vitro. Interestingly, the protective effect of DSS was markedly blocked by TAF9 knockdown. Mechanistically, TAF9 was shown to be deacetylated by HDAC1, which regulates the capacity of TAF9 to mediate fatty acid β-oxidation and LD accumulation during NAFLD. In conclusion, TAF9 is a key regulator in the treatment of NAFLD that acts by increasing fatty acid β-oxidation and reducing LD accumulation, and DSS confers protection against NAFLD through the HDAC1/TAF9 pathway. |
| format |
article |
| author |
Ruiwen Wang Zhecheng Wang Ruimin Sun Rong Fu Yu Sun Meiyang Zhu Yunfei Geng Dongyan Gao Xiaofeng Tian Yan Zhao Jihong Yao |
| author_facet |
Ruiwen Wang Zhecheng Wang Ruimin Sun Rong Fu Yu Sun Meiyang Zhu Yunfei Geng Dongyan Gao Xiaofeng Tian Yan Zhao Jihong Yao |
| author_sort |
Ruiwen Wang |
| title |
Activation of TAF9 via Danshensu-Induced Upregulation of HDAC1 Expression Alleviates Non-alcoholic Fatty Liver Disease |
| title_short |
Activation of TAF9 via Danshensu-Induced Upregulation of HDAC1 Expression Alleviates Non-alcoholic Fatty Liver Disease |
| title_full |
Activation of TAF9 via Danshensu-Induced Upregulation of HDAC1 Expression Alleviates Non-alcoholic Fatty Liver Disease |
| title_fullStr |
Activation of TAF9 via Danshensu-Induced Upregulation of HDAC1 Expression Alleviates Non-alcoholic Fatty Liver Disease |
| title_full_unstemmed |
Activation of TAF9 via Danshensu-Induced Upregulation of HDAC1 Expression Alleviates Non-alcoholic Fatty Liver Disease |
| title_sort |
activation of taf9 via danshensu-induced upregulation of hdac1 expression alleviates non-alcoholic fatty liver disease |
| publisher |
Frontiers Media S.A. |
| publishDate |
2021 |
| url |
https://doaj.org/article/5e91aa1943114e12a54876c54199f945 |
| work_keys_str_mv |
AT ruiwenwang activationoftaf9viadanshensuinducedupregulationofhdac1expressionalleviatesnonalcoholicfattyliverdisease AT zhechengwang activationoftaf9viadanshensuinducedupregulationofhdac1expressionalleviatesnonalcoholicfattyliverdisease AT ruiminsun activationoftaf9viadanshensuinducedupregulationofhdac1expressionalleviatesnonalcoholicfattyliverdisease AT rongfu activationoftaf9viadanshensuinducedupregulationofhdac1expressionalleviatesnonalcoholicfattyliverdisease AT yusun activationoftaf9viadanshensuinducedupregulationofhdac1expressionalleviatesnonalcoholicfattyliverdisease AT meiyangzhu activationoftaf9viadanshensuinducedupregulationofhdac1expressionalleviatesnonalcoholicfattyliverdisease AT yunfeigeng activationoftaf9viadanshensuinducedupregulationofhdac1expressionalleviatesnonalcoholicfattyliverdisease AT dongyangao activationoftaf9viadanshensuinducedupregulationofhdac1expressionalleviatesnonalcoholicfattyliverdisease AT xiaofengtian activationoftaf9viadanshensuinducedupregulationofhdac1expressionalleviatesnonalcoholicfattyliverdisease AT yanzhao activationoftaf9viadanshensuinducedupregulationofhdac1expressionalleviatesnonalcoholicfattyliverdisease AT jihongyao activationoftaf9viadanshensuinducedupregulationofhdac1expressionalleviatesnonalcoholicfattyliverdisease |
| _version_ |
1718395343922528256 |